Literature DB >> 12205585

Parametric imaging of tumor perfusion using flow- and permeability-limited tracers.

Liora Bogin1, Raanan Margalit, Joel Mispelter, Hadassa Degani.   

Abstract

PURPOSE: To quantitatively evaluate the spatial distribution of flow- and permeability-limited perfusion in MCF7 human breast cancer tumors orthotopically implanted in CD1-NU mice.
MATERIALS AND METHODS: Flow-limited perfusion was derived from (2)H-MRI recorded before and after infusion of deuterated water. Permeability-limited perfusion was evaluated from GdDTPA-enhanced (1)H-MRI.
RESULTS: The dominant processes in tumor perfusion, namely blood flow and capillary permeability, were mapped in orthotopically implanted MCF7 human breast cancer tumors. The dynamic data were processed according to physiological models, yielding parametric maps of intravascular volume fraction, water perfusion rate, GdDTPA permeability rate constant, and extracellular volume fraction accessible to GdDTPA. The maps exhibited the heterogeneous distribution of each perfusion parameter. Most of the tumor tissue (> or =95%) was perfused with HDO, while GdDTPA was perfused in only about 50% of it. In most loci the perfusion rate was limited by capillary permeability to GdDTPA.
CONCLUSION: The results demonstrated the instructive value of tracers with different properties used in conjunction to achieve a deeper understanding of tumor perfusion capacity. This study offers tools for the accurate, noninvasive evaluation of drug delivery efficacy. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12205585     DOI: 10.1002/jmri.10159

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  9 in total

1.  Dynamic susceptibility contrast-enhanced perfusion and conventional MR imaging findings for adult patients with cerebral primitive neuroectodermal tumors.

Authors:  Meng Law; Khuram Kazmi; Stephan Wetzel; Edwin Wang; Codrin Iacob; David Zagzag; John G Golfinos; Glyn Johnson
Journal:  AJNR Am J Neuroradiol       Date:  2004 Jun-Jul       Impact factor: 3.825

2.  [11C]methionine PET, histopathology, and survival in primary brain tumors and recurrence.

Authors:  S Ceyssens; K Van Laere; T de Groot; J Goffin; G Bormans; L Mortelmans
Journal:  AJNR Am J Neuroradiol       Date:  2006-08       Impact factor: 3.825

3.  Comparison of cerebral blood volume and vascular permeability from dynamic susceptibility contrast-enhanced perfusion MR imaging with glioma grade.

Authors:  Meng Law; Stanley Yang; James S Babb; Edmond A Knopp; John G Golfinos; David Zagzag; Glyn Johnson
Journal:  AJNR Am J Neuroradiol       Date:  2004-05       Impact factor: 3.825

4.  A prospective study on the added value of pulsed arterial spin-labeling and apparent diffusion coefficients in the grading of gliomas.

Authors:  H S Kim; S Y Kim
Journal:  AJNR Am J Neuroradiol       Date:  2007-09-20       Impact factor: 3.825

5.  Src inhibitor reduces permeability without disturbing vascularization and prevents bone destruction in steroid-associated osteonecrotic lesions in rabbits.

Authors:  Yi-Xin He; Jin Liu; Baosheng Guo; Yi-Xiang Wang; Xiaohua Pan; Defang Li; Tao Tang; Yang Chen; Songlin Peng; Zhaoxiang Bian; Zicai Liang; Bao-Ting Zhang; Aiping Lu; Ge Zhang
Journal:  Sci Rep       Date:  2015-03-09       Impact factor: 4.379

6.  Influence of spatial resolution on the accuracy of quantitative myocardial perfusion in first pass stress perfusion CMR.

Authors:  Niloufar Zarinabad; Amedeo Chiribiri; Gilion L T F Hautvast; Marcel Breeuwer; Eike Nagel
Journal:  Magn Reson Med       Date:  2014-05-20       Impact factor: 4.668

7.  Compartment model predicts VEGF secretion and investigates the effects of VEGF trap in tumor-bearing mice.

Authors:  Stacey D Finley; Manjima Dhar; Aleksander S Popel
Journal:  Front Oncol       Date:  2013-07-30       Impact factor: 6.244

8.  Mechanistic modeling quantifies the influence of tumor growth kinetics on the response to anti-angiogenic treatment.

Authors:  Thomas D Gaddy; Qianhui Wu; Alyssa D Arnheim; Stacey D Finley
Journal:  PLoS Comput Biol       Date:  2017-12-21       Impact factor: 4.475

9.  Validation of [18F]FLT as a perfusion-independent imaging biomarker of tumour response in EGFR-mutated NSCLC patients undergoing treatment with an EGFR tyrosine kinase inhibitor.

Authors:  R Iqbal; G M Kramer; V Frings; E F Smit; O S Hoekstra; R Boellaard
Journal:  EJNMMI Res       Date:  2018-03-27       Impact factor: 3.138

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.